Related Experiment Video
Updated: Aug 15, 2026
11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
The Somogyi phenomenon in insulin-dependent diabetics
The Nursing Clinics of North America
|September 1, 1977
Summary
Managing insulin-dependent diabetes requires adjusting insulin doses during stress. Proper documentation helps identify the Somogyi phenomenon, a rebound hyperglycemia from insulin overdosage.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Insulin-dependent diabetics (Type 1) require precise insulin management.
- Stress significantly impacts blood glucose levels, necessitating insulin dosage adjustments.
- Inaccurate insulin dosing can lead to hypoglycemia followed by rebound hyperglycemia (Somogyi phenomenon).
Purpose of the Study:
- To highlight the challenge of determining correct insulin dosages during stress in diabetics.
- To explain the Somogyi phenomenon as a complication of insulin overdosage.
- To advocate for systematic data collection and documentation to aid in recognizing this phenomenon.
Main Methods:
- Review of clinical scenarios and physiological responses in insulin-dependent diabetes.
- Emphasis on the importance of patient and nurse data collection.
- Proposal of a tool for enhanced recognition and evaluation of the Somogyi phenomenon.
Main Results:
- Inadequate data collection hinders the identification of insulin overdosage and subsequent Somogyi phenomenon.
- Systematic documentation provides crucial insights for physicians and nurses.
- A structured approach can improve the recognition and clinical evaluation of rebound hyperglycemia.
Conclusions:
- Accurate insulin dosage adjustments are critical for diabetics experiencing stress.
- The Somogyi phenomenon is a recognizable complication that can be identified through diligent data tracking.
- Implementing a standardized documentation tool can improve patient outcomes by facilitating early detection and management.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...